3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
21
Neoplasms
13
Breast Neoplasms
8
Lung Neoplasms
6
Pancreatic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Lymphoma
3
Recurrence
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Leukemia
2
Fatigue
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcopenia
1
Rectal Neoplasms
1
Quality of Life
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Neurocognitive Disorders
1
Neoplasms, Plasma Cell
1
Muscular Atrophy
1
Melanoma
1
Interventions
Gemcitabine
6
Cisplatin
6
pembrolizumab
3
durvalumab
3
Oxaliplatin
3
tivozanib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trametinib
1
tislelizumab
1
olaparib
1
atezolizumab
1
Yttrium-90
1
Stents
1
Radiosurgery
1
Nivolumab
1
Leucovorin
1
Ipilimumab
1
Folfox protocol
1
Fluorouracil
1
Floxuridine
1
Dexamethasone
1
Capecitabine
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bile Duct Neoplasms
×
Exercise
×
90 days
×
Clear all
No trials found.